about
Efficacy of coronary revascularization in patients with acute chest pain managed in a chest pain unitUncontrolled immune response in acute myocardial infarction: unraveling the thread.Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study.Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms.Effect of ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction. Results of a randomized study in patients and of an experimental model in swine.High-sensitivity troponin T and the risk of recurrent readmissions after hospitalisation for acute heart failure.Prognostic Value of Geriatric Conditions Beyond Age After Acute Coronary Syndrome.Clinical Evaluation Versus Undetectable High-Sensitivity Troponin for Assessment of Patients With Acute Chest Pain.Incidence, Outcomes, and Predictors of Ventricular Thrombus after Reperfused ST-Segment-Elevation Myocardial Infarction by Using Sequential Cardiac MR Imaging.Utility of Procalcitonin for Diagnosis of Superimposed Infections in Patients With Acute Heart Failure.Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study.Metformin and risk of long-term mortality following an admission for acute heart failure.Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function.Procalcitonin and long-term prognosis after an admission for acute heart failure.Usefulness and safety of a guide catheter extension system for the percutaneous treatment of complex coronary lesions by a transradial approach.Acute myocardial infarction: high risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus.Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI.CA125 and immunoinflammatory activity in acute heart failure.Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome.Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction.[Acute coronary syndrome complicated by heart failure as predictor of long-term infarction].Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction.Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients.Limitations of clinical history for evaluation of patients with acute chest pain, non-diagnostic electrocardiogram, and normal troponin.Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.Worsening Renal Function in Acute Decompensated Heart Failure: The Puzzle is Still Incomplete.Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure.Percutaneous coronary intervention and recurrent hospitalizations in elderly patients with non ST-segment acute coronary syndrome: The role of frailty.Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.Usefulness of sheathless guide catheter for the percutaneous coronary intervention of left main disease by radial approach.Non-ST-elevation acute myocardial infarction with normal coronary arteries: predictors and prognosis.A Multidisciplinary Assessment of Remote Myocardial Fibrosis After Reperfused Myocardial Infarction in Swine and Patients.Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels.Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study.Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction.Inhomogeneity of collagen organization within the fibrotic scar after myocardial infarction: results in a swine model and in human samples.Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction.Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure.
P50
Q37151370-384B6F7B-1D28-454D-A0FB-0C26CAA52DF9Q37334566-61B4587A-579C-4683-97E2-CACD60B685CAQ37411942-27A185C3-0050-48B6-B6C3-B988820C3F6FQ38372743-567DFF35-DDF4-4B9E-B702-F338208C650AQ38429771-7CDBBA01-DC86-4605-9405-4C04BC5574D5Q38787626-5440A6D5-9443-45BC-90F1-AE78D5E5E075Q38847488-076C1367-3939-4ED0-8106-FF64DADAB69BQ39354228-33F89151-A277-43ED-8E82-BFD3328FD704Q40311447-57443439-882B-4FE8-B632-DD1A563F7F4DQ40351205-636ADC58-49AD-4F78-B8B9-FDE7A19EA1CFQ40649865-0855013F-11EB-45E7-8CA4-E6A3DF7D47B0Q40683496-A8D3C57C-F8EE-4433-8478-1CC202858C4FQ40811370-DCF6CF30-199B-43AD-82F2-863B7EEEC5CAQ41542676-38708BBB-513E-49EB-956A-D26B89F41796Q41660072-1A6AA050-789B-4082-B608-8383EB1A41E5Q43875187-3E1E0801-88B3-41FE-94C0-C01985FFD61CQ43952152-0EE77889-5C0D-4A72-B84F-B2427312D7B1Q44299997-9E78866B-B4C0-4F1E-9F6F-7F1EA4CC1F99Q44309888-D8061392-6D69-4C03-94AD-D2B2129C2D23Q44433455-3CC1BCC3-C81B-4BC0-8ABD-2D576BD99873Q44489340-27B1A8B4-9DE1-4207-9573-A8387A593CF4Q44851959-3C898BFA-6911-4D1C-8FF1-8E1C5B38621EQ45902457-6344FC05-C212-44C7-8CC3-FB4EE0A25838Q46297326-6DBABE28-F860-4DE5-AD31-9BFE2333C285Q46727646-EC376248-575A-4E05-B65D-180AAE967E34Q48663975-CE13D8E6-11AD-4AF9-9B94-D11CE464E597Q48807044-5CE60662-271E-4F94-8493-6F6A67BC214CQ49023261-416A61BC-0C11-4D23-9E85-A9449A282949Q51035882-41BEFBF8-7B7A-490D-B326-A36674B1DF72Q51054278-A278BD56-F3AF-4CCE-971D-91873A507DE3Q51075572-CAB69241-8CD5-4669-8245-CDE0349083E5Q51445731-100F09F1-8856-4D7A-8CFB-D3E673337869Q51605233-FCB07E43-D773-4327-9665-8B0B71BECAECQ51725730-FDAC4E13-3B52-49E5-8852-D08039BB4F87Q51810512-5B9A2428-1BB5-46AB-9DCF-568A3984ABE0Q52583890-03E1B10F-8141-4C11-8F1B-F544C37038C8Q52992042-6ED83905-C2AB-4451-B860-3812473A46A9Q53297295-ECDFB11A-5FFC-468C-9015-0A46EB2EFE47Q53350286-4F6438D7-C74C-4E74-BEF0-D52EDA24EC68Q53729769-B4CBF562-D923-4505-A72F-D6E66712BEB6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Gema Miñana
@en
Gema Miñana
@nl
type
label
Gema Miñana
@en
Gema Miñana
@nl
prefLabel
Gema Miñana
@en
Gema Miñana
@nl
P31
P496
0000-0001-8777-2588